Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7878546 | 1.00 | ALDH1A1 (0.46) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL1063406 | 1.00 | ALDH1A1 (0.46) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL997657 | 0.90 | ALDH1A1 (0.40) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL2426057 | 0.89 | MEN1 (0.55) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL9581365 | 0.89 | MEN1 (0.55) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL27881166 | 0.89 | MEN1 (0.55) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL12317070 | 0.89 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL3672194 | 0.89 | MEN1 (0.55) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL9333587 | 0.87 | TSHR (0.41) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL9333535 | 0.87 | TSHR (0.41) | ALDH1A1TSHRTP53HIF1AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | claimed |
| EP-4471010-B1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INT BV (NL) | 2025-06-04 | — | — | EP | claimed |
| CN-119439655-A | Corrosion-resistant developing solution and preparation method and application thereof | 上海戎洲芯科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | claimed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | claimed |
| CN-119059951-A | Process for preparing peroxyesters or peroxycarbonates | 诺力昂化学品国际有限公司 | 2024-12-03 | — | — | CN | claimed |
| EP-2373633-B1 | METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES | BOREALIS AGROLINZ MELAMINE (AT) | 2014-04-16 | — | — | EP | claimed |
| US-20110295001-A1 | Method for Producing Triazine Carbamates Using Chloroformates | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2011-12-01 | — | — | US | claimed |
| US-7998375-B2 | Method of manufacturing high strength dental restorations | PENTRON CLINICAL TECHNOLOGIES, LLC (US) | 2011-08-16 | — | — | US | claimed |
| EP-1973587-A2 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | Allaccem, Inc. (US) | 2008-10-01 | — | — | EP | claimed |
| WO-2007070801-A2 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | ALLACCEM, INC. (US) | 2007-06-21 | — | — | WO | claimed |
| US-7115581-B2 | Chemically-defined non-polymeric valency platform molecules and conjugates thereof | LA JOLLA PHARMACEUTICAL COMPANY (US) | 2006-10-03 | — | — | US | claimed |
| US-20040241609-A1 | Method of manufacturing high strength dental restorations | PENTRON LABORATORY TECHNOLOGIES, LLC | 2004-12-02 | — | — | US | claimed |
| US-6362250-B1 | FIBER REINFORCEMENT POLYMER MATRIX | JENERIC/PENTRON INCORPORATED | 2002-03-26 | — | — | US | claimed |
| US-6326417-B1 | CONTAINING SALICYLIC ACID COMPOUND AS MICROBIOCIDES | JENERIC/PENTRON INCORPORATED | 2001-12-04 | — | — | US | claimed |
| EP-1036806-A2 | Polymeric materials of the polyester-carbonate family and reactions for the formation of such materials | EVC Compounds (Italia) S.p.A. (IT) | 2000-09-20 | — | — | EP | claimed |
| US-5969000-A | CURABLE DENTAL RESIN COMPRISING METHACRYLATE OLIGOMER, ETHOXYLATED BISPHENOL A DIMETHACRYLATE, DILUENT MONOMER FOR DECREASING VISCOSITY | JENERIC PENTRON INCORPORATED (US) | 1999-10-19 | — | — | US | claimed |
| EP-0853939-A2 | Dental resin materials | JENERIC/PENTRON Incorporated (US) | 1998-07-22 | — | — | EP | claimed |
| US-5444104-A | Dental restorative material based on a polycarbonate dimethacrylate | JENERIC/PENTRON, INC. (US) | 1995-08-22 | — | — | US | claimed |
| US-5276068-A | Dimethacrylate compounds containing carbonate groups, adhesives, restoration material | JENERIC/PENTRON, INC. (US) | 1994-01-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110295001-A1 | Method for Producing Triazine Carbamates Using Chloroformates | CA3, CA7, KAT5 | ALDH1A1 1014/4885TSHR 244/4885TP53 1275/4885 |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | GPX4, PRDX4, PRDX2 | ALDH1A1 327/4885TSHR 2104/4885TP53 3413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.